Cargando…
A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines
LINE-1 elements make up the most abundant retrotransposon family in the human genome. Full-length LINE-1 elements encode a reverse transcriptase (RT) activity required for their own retrotranpsosition as well as that of non-autonomous Alu elements. LINE-1 are poorly expressed in normal cells and abu...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926826/ https://www.ncbi.nlm.nih.gov/pubmed/24345856 |
_version_ | 1782304023177592832 |
---|---|
author | Sciamanna, Ilaria Gualtieri, Alberto Cossetti, Cristina Osimo, Emanuele Felice Ferracin, Manuela Macchia, Gianfranco Aricò, Eleonora Prosseda, Gianni Vitullo, Patrizia Misteli, Tom Spadafora, Corrado |
author_facet | Sciamanna, Ilaria Gualtieri, Alberto Cossetti, Cristina Osimo, Emanuele Felice Ferracin, Manuela Macchia, Gianfranco Aricò, Eleonora Prosseda, Gianni Vitullo, Patrizia Misteli, Tom Spadafora, Corrado |
author_sort | Sciamanna, Ilaria |
collection | PubMed |
description | LINE-1 elements make up the most abundant retrotransposon family in the human genome. Full-length LINE-1 elements encode a reverse transcriptase (RT) activity required for their own retrotranpsosition as well as that of non-autonomous Alu elements. LINE-1 are poorly expressed in normal cells and abundantly in cancer cells. Decreasing RT activity in cancer cells, by either LINE-1-specific RNA interference, or by RT inhibitory drugs, was previously found to reduce proliferation and promote differentiation and to antagonize tumor growth in animal models. Here we have investigated how RT exerts these global regulatory functions. We report that the RT inhibitor efavirenz (EFV) selectively downregulates proliferation of transformed cell lines, while exerting only mild effects on non-transformed cells; this differential sensitivity matches a differential RT abundance, which is high in the former and undetectable in the latter. Using CsCl density gradients, we selectively identify Alu and LINE-1 containing DNA:RNA hybrid molecules in cancer but not in normal cells. Remarkably, hybrid molecules fail to form in tumor cells treated with EFV under the same conditions that repress proliferation and induce the reprogramming of expression profiles of coding genes, microRNAs (miRNAs) and ultraconserved regions (UCRs). The RT-sensitive miRNAs and UCRs are significantly associated with Alu sequences. The results suggest that LINE-1-encoded RT governs the balance between single-stranded and double-stranded RNA production. In cancer cells the abundant RT reverse-transcribes retroelement-derived mRNAs forming RNA:DNA hybrids. We propose that this impairs the formation of double-stranded RNAs and the ensuing production of small regulatory RNAs, with a direct impact on gene expression. RT inhibition restores the ‘normal’ small RNA profile and the regulatory networks that depend on them. Thus, the retrotransposon-encoded RT drives a previously unrecognized mechanism crucial to the transformed state in tumor cells. |
format | Online Article Text |
id | pubmed-3926826 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-39268262014-02-18 A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines Sciamanna, Ilaria Gualtieri, Alberto Cossetti, Cristina Osimo, Emanuele Felice Ferracin, Manuela Macchia, Gianfranco Aricò, Eleonora Prosseda, Gianni Vitullo, Patrizia Misteli, Tom Spadafora, Corrado Oncotarget Research Paper LINE-1 elements make up the most abundant retrotransposon family in the human genome. Full-length LINE-1 elements encode a reverse transcriptase (RT) activity required for their own retrotranpsosition as well as that of non-autonomous Alu elements. LINE-1 are poorly expressed in normal cells and abundantly in cancer cells. Decreasing RT activity in cancer cells, by either LINE-1-specific RNA interference, or by RT inhibitory drugs, was previously found to reduce proliferation and promote differentiation and to antagonize tumor growth in animal models. Here we have investigated how RT exerts these global regulatory functions. We report that the RT inhibitor efavirenz (EFV) selectively downregulates proliferation of transformed cell lines, while exerting only mild effects on non-transformed cells; this differential sensitivity matches a differential RT abundance, which is high in the former and undetectable in the latter. Using CsCl density gradients, we selectively identify Alu and LINE-1 containing DNA:RNA hybrid molecules in cancer but not in normal cells. Remarkably, hybrid molecules fail to form in tumor cells treated with EFV under the same conditions that repress proliferation and induce the reprogramming of expression profiles of coding genes, microRNAs (miRNAs) and ultraconserved regions (UCRs). The RT-sensitive miRNAs and UCRs are significantly associated with Alu sequences. The results suggest that LINE-1-encoded RT governs the balance between single-stranded and double-stranded RNA production. In cancer cells the abundant RT reverse-transcribes retroelement-derived mRNAs forming RNA:DNA hybrids. We propose that this impairs the formation of double-stranded RNAs and the ensuing production of small regulatory RNAs, with a direct impact on gene expression. RT inhibition restores the ‘normal’ small RNA profile and the regulatory networks that depend on them. Thus, the retrotransposon-encoded RT drives a previously unrecognized mechanism crucial to the transformed state in tumor cells. Impact Journals LLC 2013-10-14 /pmc/articles/PMC3926826/ /pubmed/24345856 Text en Copyright: © 2013 Sciamanna et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Sciamanna, Ilaria Gualtieri, Alberto Cossetti, Cristina Osimo, Emanuele Felice Ferracin, Manuela Macchia, Gianfranco Aricò, Eleonora Prosseda, Gianni Vitullo, Patrizia Misteli, Tom Spadafora, Corrado A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines |
title | A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines |
title_full | A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines |
title_fullStr | A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines |
title_full_unstemmed | A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines |
title_short | A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines |
title_sort | tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926826/ https://www.ncbi.nlm.nih.gov/pubmed/24345856 |
work_keys_str_mv | AT sciamannailaria atumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT gualtierialberto atumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT cossetticristina atumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT osimoemanuelefelice atumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT ferracinmanuela atumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT macchiagianfranco atumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT aricoeleonora atumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT prossedagianni atumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT vitullopatrizia atumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT mistelitom atumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT spadaforacorrado atumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT sciamannailaria tumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT gualtierialberto tumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT cossetticristina tumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT osimoemanuelefelice tumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT ferracinmanuela tumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT macchiagianfranco tumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT aricoeleonora tumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT prossedagianni tumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT vitullopatrizia tumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT mistelitom tumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines AT spadaforacorrado tumorpromotingmechanismmediatedbyretrotransposonencodedreversetranscriptaseisactiveinhumantransformedcelllines |